CASP1 and graft versus host disease: DAMP molecules enhance GVHD through cleavage of precursor intracellular cytokine pro-interleukin-1β into its bioactive form by caspase-1 or caspase-11, and through the transcription of genes that encode cytokines and chemokines that promote GVHD.